Cholic acid [81-25-4]
Référence M9192-500mg
Conditionnement : 500mg
Marque : AbMole Bioscience
All AbMole products are for research use only, cannot be used for human consumption.

Quality Control & Documentation
Biological Activity
Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion.
Protocol (for reference only)
| Cell Experiment | |
|---|---|
| Cell lines | HepG2 cells |
| Preparation method | HepG2 cells are pretreated with the inhibitors NaN3 (1 mg/mL), Genistein (50 μg/mL), MβCD (10 mM), Nystatin (50 μg/mL), Chlorpromazine (10 μg/mL), and Cholic acid (1 mg/mL) for 30 min. After removing the inhibitors, the cells are incubated with CA-LPs for 2 h, and the cellular uptake of LPs is determined in the "In vitro cellular uptake assays" section. |
| Concentrations | 1 mg/mL |
| Incubation time | 30 min |
| Animal Experiment | |
|---|---|
| Animal models | Tg-CYP2D6 mice |
| Formulation | 1% (w/w) Cholic acid-supplemented |
| Dosages | 14 days |
| Administration | fed |
Chemical Information
| Molecular Weight | 408.57 |
| Formula | C24H40O5 |
| CAS Number | 81-25-4 |
| Solubility (25°C) | DMSO: ≥ 40 mg/mL |
| Storage | 4°C, dry, sealed |
References
[1] Li Y, et al. Int J Nanomedicine. Mechanism of hepatic targeting via oral administration of DSPE-PEG-cholic acid-modified nanoliposomes.

